Scopus Biopharma Inc (SCPS)

NASDAQ
4.700
-0.420(-8.20%)
  • Volume:
    333,837
  • Bid/Ask:
    4.720/4.840
  • Day's Range:
    4.600 - 5.240

SCPS Overview

Prev. Close
5.12
Day's Range
4.6-5.24
Revenue
-
Open
5.19
52 wk Range
4.6-47.86
EPS
-
Volume
333,837
Market Cap
73.92M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
15,727,597
Next Earnings Date
Dec 01, 2021
What is your sentiment on Scopus Biopharma Inc?
or
Market is currently closed. Voting is open during market hours.

Scopus Biopharma Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

Scopus Biopharma Inc Company Profile

Scopus Biopharma Inc Company Profile

Employees
1

Scopus BioPharma Inc. is a biotechnology company. The Company is focused on developing therapeutics targeting serious diseases. The Company’s lead program targets immuno-oncology gene therapy for the treatment of multiple cancers. Its lead development program is CpG-STAT3siRNA (CO-sTiRNA), which is in Phase I clinical trial, is a STAT3 inhibitor gene therapy. CO-sTiRNA is developed for the treatment of B-cell non-Hodgkins lymphoma. It also stimulates TLR9 receptors to activate the body’s immune defense to kill cancer cells. Its second development program is in pre-clinical stage MRI-1867, a cannabinoid receptor mediating compound for the treatment of systemic sclerosis. MRI-1867 is a small molecule that is an inverse agonist of the cannabinoid-1 receptor (CB1), as well as an inhibitor of the inducible nitric oxide synthase (iNOS) system.

Read More
  • $9.30
    0
    • 2021.05.27 JB @ $8.00
      0
      • No Pulses need EKG
        0
        • what is going on here I don't understand
          0
          • it opened at 21$ way too high. not worth this valuation
            1
            • trading at 41$ this is crazy
              1
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.